ENDRA LIFE SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2748 USD | -2.62% |
|
-9.28% | -87.04% |
| 05-14 | Transcript : ENDRA Life Sciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| 05-14 | Endra Life Sciences Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENDRA LIFE SCIENCES INC. | Other Biotechnology & Medical Research | -2.62% | -9.28% | -87.04% | -82.38% | -98.68% | 3.11M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- NDRA Stock
- Charts ENDRA Life Sciences Inc.
- Comparison Chart
